Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study

Publication | Open Access

DOI Full Paper Access

338

Citations

References

2017

Year

Deverick J. Anderson, Luke F. Chen, David J. Weber, Rebekah W. Moehring, Sarah S. Lewis, Patricia Triplett, Michael Blocker, Paul Becherer, J. Conrad Schwab, Lauren P. Knelson,

The Lancet

Antimicrobial SusceptibilityHealth SciencesAntibioticsClostridium DifficileHealthcare-associated InfectionMicrobiologyInfection ControlMultidrug-resistant OrganismsCrossover StudyMedicineDisinfectantClinical MicrobiologyAntimicrobial ResistanceDrug Resistance